01 52Bayer Inc.
01 92396561
02 22451258
03 132547113
04 132624310
05 132823159
06 22993858
01 40RIVAROXABAN
02 12Rivaroxaban
01 12GRANULES FOR SUSPENSION
02 28TABLET
03 12Tablet
01 92020-12-11
02 22022-06-07
03 132024-11-13
04 262026-09-22
05 22038-02-02
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Brand Name : XARELTO
Patent Number : 2396561
Filing Date : 2000-12-11
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Brand Name : XARELTO
Patent Number : 2396561
Filing Date : 2000-12-11
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Brand Name : XARELTO
Patent Number : 2396561
Filing Date : 2000-12-11
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Brand Name : XARELTO
Patent Number : 2624310
Filing Date : 2006-09-22
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Patent Expiration Date : 2024-11-13
Date Granted : 2012-01-24
Brand Name : XARELTO
Patent Number : 2547113
Filing Date : 2004-11-13
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-11-13
Date Granted : 2012-01-24
Patent Expiration Date : 2026-09-22
Date Granted : 2014-10-21
Brand Name : XARELTO
Patent Number : 2823159
Filing Date : 2006-09-22
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-10-21
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Brand Name : XARELTO
Patent Number : 2624310
Filing Date : 2006-09-22
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Patent Expiration Date : 2024-11-13
Date Granted : 2012-01-24
Brand Name : XARELTO
Patent Number : 2547113
Filing Date : 2004-11-13
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-11-13
Date Granted : 2012-01-24
Patent Expiration Date : 2026-09-22
Date Granted : 2014-10-21
Brand Name : XARELTO
Patent Number : 2823159
Filing Date : 2006-09-22
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-10-21
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Brand Name : XARELTO
Patent Number : 2624310
Filing Date : 2006-09-22
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
